Last reviewed · How we verify

Airtal® film-coated tablet 100 mg

Pharmtechnology LLC · Phase 1 active Small molecule Quality 0/100

Airtal® film-coated tablet 100 mg is a Small molecule drug developed by Pharmtechnology LLC. It is currently in Phase 1 development. Also known as: The reference product.

At a glance

Generic nameAirtal® film-coated tablet 100 mg
Also known asThe reference product
SponsorPharmtechnology LLC
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Airtal® film-coated tablet 100 mg

What is Airtal® film-coated tablet 100 mg?

Airtal® film-coated tablet 100 mg is a Small molecule drug developed by Pharmtechnology LLC.

Who makes Airtal® film-coated tablet 100 mg?

Airtal® film-coated tablet 100 mg is developed by Pharmtechnology LLC (see full Pharmtechnology LLC pipeline at /company/pharmtechnology-llc).

Is Airtal® film-coated tablet 100 mg also known as anything else?

Airtal® film-coated tablet 100 mg is also known as The reference product.

What development phase is Airtal® film-coated tablet 100 mg in?

Airtal® film-coated tablet 100 mg is in Phase 1.

Related